ES552145A0 - Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico. - Google Patents

Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.

Info

Publication number: ES552145A0
Authority: ES; Spain
Prior art keywords: oral administration; manufacturing procedure; dosing unit; potassic; chloride
Prior art date: 1985-02-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

ES552145A

Other languages

English (en)

Other versions

ES8801121A1 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Key Pharmaceuticals Inc

Original Assignee

Key Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-02-19

Filing date

1986-02-18

Publication date

1988-01-01

1986-02-18 Application filed by Key Pharmaceuticals Inc filed Critical Key Pharmaceuticals Inc

1988-01-01 Publication of ES552145A0 publication Critical patent/ES552145A0/es

1988-01-01 Publication of ES8801121A1 publication Critical patent/ES8801121A1/es

Status Expired legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Lubricants (AREA)

ES552145A 1985-02-19 1986-02-18 Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico. Expired ES8801121A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US70271485A	1985-02-19	1985-02-19

Publications (2)

Publication Number	Publication Date
ES552145A0 true ES552145A0 (es)	1988-01-01
ES8801121A1 ES8801121A1 (es)	1988-01-01

Family

ID=24822313

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES552145A Expired ES8801121A1 (es)	1985-02-19	1986-02-18	Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.

Country Status (13)

Country	Link
EP (1)	EP0211946B1 (es)
JP (1)	JPH0625064B2 (es)
AU (1)	AU583903B2 (es)
DE (1)	DE3671373D1 (es)
DK (1)	DK165123C (es)
ES (1)	ES8801121A1 (es)
FI (1)	FI87528C (es)
GR (1)	GR860479B (es)
IE (1)	IE59066B1 (es)
NZ (1)	NZ215241A (es)
SG (1)	SG120392G (es)
WO (1)	WO1986004817A1 (es)
ZA (1)	ZA861242B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4704285A (en) *	1985-11-18	1987-11-03	The Dow Chemical Company	Sustained release compositions comprising hydroxypropyl cellulose ethers
US4710384A (en) *	1986-07-28	1987-12-01	Avner Rotman	Sustained release tablets made from microcapsules
GB8628359D0 (en) *	1986-11-27	1986-12-31	Zyma Sa	Galenical formulation
GB8702411D0 (en) *	1987-02-03	1987-03-11	Zyma Sa	Swellable pellets
US5009897A (en) *	1988-06-24	1991-04-23	Abbott Laboratories	Pharmaceutical granules and tablets made therefrom
IE63242B1 (en) *	1988-06-24	1995-04-05	Abbott Lab	Pharmaceutical granules and tablets made therefrom
US5612059A (en) *	1988-08-30	1997-03-18	Pfizer Inc.	Use of asymmetric membranes in delivery devices
DK0542926T3 (da) *	1990-08-07	1995-05-15	Pfizer	Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
US5436011A (en) *	1993-04-16	1995-07-25	Bristol-Myers Squibb Company	Solid pharmaceutical dosage form and a method for reducing abrasion
US5397574A (en) *	1993-10-04	1995-03-14	Andrx Pharmaceuticals, Inc.	Controlled release potassium dosage form
US5458888A (en) *	1994-03-02	1995-10-17	Andrx Pharmaceuticals, Inc.	Controlled release tablet formulation
DK1067910T3 (da)	1998-04-03	2004-10-04	Egalet As	Komposition med styret afgivelse
EP1429739A1 (en)	2001-09-21	2004-06-23	Egalet A/S	Polymer release system
WO2003024430A1 (en)	2001-09-21	2003-03-27	Egalet A/S	Morphine polymer release system
EP1562552A1 (en)	2002-11-08	2005-08-17	Egalet A/S	Controlled release carvedilol compositions
ES2570454T3 (es)	2003-03-26	2016-05-18	Egalet Ltd	Sistema de liberación controlada de morfina
EP1974726B1 (en)	2003-03-26	2010-01-13	Egalet A/S	Matrix compositions for controlled delivery of drug substances
EP2155167A2 (en)	2007-06-04	2010-02-24	Egalet A/S	Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en)	2009-02-06	2010-08-12	Egalet A/S	Immediate release composition resistant to abuse by intake of alcohol
CA2766179A1 (en)	2009-06-24	2010-12-29	Egalet Ltd.	Controlled release formulations
CN104684548A (zh)	2012-07-06	2015-06-03	埃格勒特有限责任公司	防止滥用的控释药物组合物
FR3069545B1 (fr)	2017-07-27	2020-10-16	Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic	Composition d'enrobage exempte de dioxyde de titane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4259315A (en) *	1980-06-13	1981-03-31	A. H. Robins Company, Inc.	Controlled release potassium dosage form
ATE13486T1 (de) *	1980-11-12	1985-06-15	Ciba Geigy Ag	Schnellzerfallende arzneimittel-presslinge.
US4508702A (en) *	1982-06-14	1985-04-02	Key Pharmaceuticals, Inc.	Sustained release aspirin
WO1984000004A1 (en) *	1982-06-14	1984-01-05	Key Pharma	Sustained release aspirin
CH658188A5 (de) *	1984-03-23	1986-10-31	Ciba Geigy Ag	Lagerstabile schnellzerfallende pharmazeutische presslinge.

1986
- 1986-02-18 ES ES552145A patent/ES8801121A1/es not_active Expired
- 1986-02-18 IE IE43386A patent/IE59066B1/en not_active IP Right Cessation
- 1986-02-19 ZA ZA861242A patent/ZA861242B/xx unknown
- 1986-02-19 JP JP61501241A patent/JPH0625064B2/ja not_active Expired - Fee Related
- 1986-02-19 GR GR860479A patent/GR860479B/el unknown
- 1986-02-19 DE DE8686901631T patent/DE3671373D1/de not_active Expired - Lifetime
- 1986-02-19 EP EP86901631A patent/EP0211946B1/en not_active Expired - Lifetime
- 1986-02-19 WO PCT/US1986/000318 patent/WO1986004817A1/en not_active Ceased
- 1986-02-19 AU AU55140/86A patent/AU583903B2/en not_active Ceased
- 1986-02-20 NZ NZ215241A patent/NZ215241A/xx unknown
- 1986-10-16 DK DK494986A patent/DK165123C/da active
- 1986-10-17 FI FI864207A patent/FI87528C/fi not_active IP Right Cessation
1992
- 1992-11-23 SG SG1203/92A patent/SG120392G/en unknown

Also Published As

Publication number	Publication date
GR860479B (en)	1986-06-18
JPS62501845A (ja)	1987-07-23
FI87528C (fi)	1993-01-25
IE59066B1 (en)	1993-12-15
EP0211946A1 (en)	1987-03-04
ES8801121A1 (es)	1988-01-01
DE3671373D1 (de)	1990-06-28
AU5514086A (en)	1986-09-10
FI87528B (fi)	1992-10-15
DK165123C (da)	1993-03-01
NZ215241A (en)	1988-10-28
ZA861242B (en)	1986-10-29
DK494986A (da)	1986-10-16
EP0211946B1 (en)	1990-05-23
WO1986004817A1 (en)	1986-08-28
JPH0625064B2 (ja)	1994-04-06
SG120392G (en)	1993-01-29
IE860433L (en)	1986-08-19
DK494986D0 (da)	1986-10-16
FI864207L (fi)	1986-10-17
FI864207A0 (fi)	1986-10-17
AU583903B2 (en)	1989-05-11

Publication	Publication Date	Title
ES552145A0 (es)	1988-01-01	Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
DE3681348D1 (de)	1991-10-17	Oral-arzneizubereitung mit retardwirkung.
FI863709A0 (fi)	1986-09-12	Oral sammansaettning som foerhindrar bildande av tandsten.
FI862479L (fi)	1986-12-12	Oral farmaceutisk komposition.
FI870140L (fi)	1987-01-14	Orala vacciner.
NO863652L (no)	1987-03-16	Oralt preparat mot tannstein.
DK35287A (da)	1987-07-23	Stabilt, oralt, enkelt enhedsdosisprodukt
LV5760B4 (lv)	1997-06-20	Jauns farmaceitisks preparats peroralai lietosanai
MX9202976A (es)	1992-07-01	Una preparacion de etoposido.
DK175487A (da)	1987-04-06	Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
DK520283A (da)	1984-07-04	Vandig, oral oploesning
ES557670A0 (es)	1988-07-16	Un procedimiento para la produccion de una preparacion de activador de proteina c.
FI863077L (fi)	1987-01-30	Farmaceutisk dosenhet.
ES554812A0 (es)	1988-01-01	Un procedimiento para preparar una composicion anticariogena solida para administracion oral.
IT8619496A0 (it)	1986-02-21	Spazzolino interdentale.
KR880700906A (ko)	1988-04-13	치합기구에서의 치형
NO861517L (no)	1986-10-20	Stabilt smakstoffholdig tannpleiemiddel.
MX9203559A (es)	1992-09-01	Una forma de dosificacion para administrar clorofeniramina.
ES1000119Y (es)	1988-06-01	Una tableta farmaceutica para administracion oral
ES556000A0 (es)	1987-07-16	Un procedimiento para la preparacion de una serie de piridazinas
ES553705A0 (es)	1987-09-01	Un procedimiento para la preparacion de una alcanoilanilida
IT1190483B (it)	1988-02-16	Procedimento di preparazione di una fenilurea sostituita
ES541400A0 (es)	1986-10-16	Una tableta fumigante
ES551634A0 (es)	1987-11-16	Procedimiento para la preparacion de una composicion farmaceutica a base de 3-aminopropoxiindoles
DK111786D0 (da)	1986-03-11	Oralt middel mod tandsten

Legal Events

Date	Code	Title	Description
2006-11-16	FD1A	Patent lapsed	Effective date: 20040929